• Contact Us
  • Indexing
  • Submit Manuscript
  • Open Access
  • Journals
  • Home
  • ISSN: 2379-0547
    Volume 5, Issue 6
    Letter to Editor
    Paolo Lauriola*
    Before getting my degree in Medicine and Surgery at the University of Modena, my dream was to be a researcher. Therefore I attended as an internal student the Institute of General Pathology where I dealt with biochemistry issues, in particular enzymology, and I published some papers.
    Letter to Editor
    Jose Luis Turabian*
    Four strategies can be described to increase the opportunities to identify adverse drug reactions (ADRs) and the problems related to them in general medicine, and to provide knowledge about their epidemiology in outpatient setting: 1. Contribute to the epidemiological knowledge by providing “numerators” and “denominators” (prevalence, incidence, risks): the position of the general practitioner as the gatekeeper of the health system and who attends to a list of known patients, and often with a geographical base, for long periods of time, allows him to know data of morbidity and mortality, as well as cure rates and different types of risk (Relative Irrigation, Absolute Risk, Attributable Risk, and Individual Susceptibility); 2. Case studies at this level of general medicine allow the communication of ADRs that are especially infrequent or related to new drugs; 3. Improve the knowledge of ADRs avoiding the difficulties of interpretation of symptoms or diseases that are not due to medicines but psychosocial factors, since general practitioner in his continued attention accumulates a lot of psychosocial data of the patients which may allow him to better interpret the symptoms, and also, he can perform studies incorporating external or internal controls (the patient himself as his control); And 4. The use of all this knowledge to apply to the consultation: ADRs can also teach us important things about human biology, and so the general practitioner can observe facts and hypotheses to verify, and also using that local knowledge in the ADR prevention or epidemiological monitoring.
    Review Article
    Forouzan Akrami*
    Given the growing trend of the health and medical technologies such as genomic medicine, policy makers and health professionals confronted with new ethical and legal challenges at the level of the community. Addressing these challenges and conflicts requires bioethics as it helps us to make policies more than that medical ethics does. In this narrative review after description of the Public health institution and its nature, and foundations of the public health ethics and law, despite idea of the ethics only as a consultation service for public health discipline, I argue ethics and law as the integral parts of Public health which without considering those, achievement to the main goals of public health could not be assured.
    Research Article
    Michiko Nohora, Junko Kurita, Tamie Sugawara*, and Yasushi Ohkusa
    Background: Earlier study without actual trial have indicated that caregivers need delivery of information about outbreak situations independently of their job status. This report describes, for about two months in winter, actual delivery outbreak information to families with preschool children. The study objective was to confirm the usefulness of this information delivery.
    Method: Participants receiving outbreak information were recruited from users and providers of the Child Care Support Service. Outbreak information was obtained from the Nursery School Absenteeism Surveillance System (NSASSy), prescription surveillance and others resources. Delivery of outbreak information started in December, 2017 and ceased at the end of February in 2018. After the delivery period, a questionnaire survey was administered to participants.
  • JSciMed Central Blogs
  • JSciMed Central welcomes back astronaut Scott Kelly and cosmonaut Mikhail Kornienko.

    Wonder Women Tech not only disrupted the traditional conference model but innovatively changed the way conferences should be held.

    JSciMed Central Peer-reviewed Open Access Journals
    About      |      Journals      |      Open Access      |      Special Issue Proposals      |      Guidelines      |      Submit Manuscript      |      Contacts
    Copyright © 2016 JSciMed Central All Rights Reserved
    Creative Commons Licence Open Access Publication by JSciMed Central is licensed under a Creative Commons Attribution 4.0 International License.
    Based on a work at https://jscimedcentral.com/. Permissions beyond the scope of this license may be available at https://creativecommons.org/.